Difference between revisions of "Zeno"
m |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | Zeno is a PR firm owned by Edelman formerly known as [[PR21]]. | + | {{Template:NuclearSpin}}Zeno is a PR firm owned by [[Edelman]] formerly known as [[PR21]]. |
Among its clients are [[British Nuclear Fuels Limited]] | Among its clients are [[British Nuclear Fuels Limited]] | ||
| Line 5: | Line 5: | ||
==People== | ==People== | ||
| − | Jerry A. Epstein | + | *[[Jerry A. Epstein]] President and Chief Executive Officer |
| − | President and Chief Executive Officer | + | *[[Sue Ryan]] Chief Executive Zeno Europe |
| − | Sue Ryan | + | *[[Phil Armstrong]] Managing Director and Corporate Public Affairs Lead |
| − | Chief Executive Zeno Europe | + | *[[John Berard]] Managing Director & Technology Lead |
| − | Phil Armstrong | + | *[[Bridget Brennan]] Managing Director & Consumer Marketing Lead |
| − | Managing Director and Corporate Public Affairs Lead | + | *[[Sheldon Lamphier]] Managing Director, Human Resources |
| − | John Berard | + | *[[Lisa Robinson]] Managing Director & Head Creative |
| − | Managing Director & Technology Lead | + | *[[Hiroshi Wald]] Managing Director, Research |
| − | Bridget Brennan | + | *[[Charlotte Wray]] Managing Director & Health Care Lead |
| − | Managing Director & Consumer Marketing Lead | ||
| − | Sheldon Lamphier | ||
| − | Managing Director, Human Resources | ||
| − | Lisa Robinson | ||
| − | Managing Director & Head Creative | ||
| − | Hiroshi Wald | ||
| − | Managing Director, Research | ||
| − | Charlotte Wray | ||
| − | Managing Director & Health Care Lead | ||
==Advisory Board== | ==Advisory Board== | ||
| − | Zeno claims to have an | + | Zeno claims to have an Advisory Board, and has this to say about it on its [http://www.pr21.com/AboutZ.aspx?ntopicId=317 website]: |
:ZENO approaches each assignment seeking to build the right program to solve a problem, leverage an opportunity or otherwise gain market advantage. To support the capabilities of our staff, we have created an advisory board of industry and communications experts who play important roles on our delivery teams. | :ZENO approaches each assignment seeking to build the right program to solve a problem, leverage an opportunity or otherwise gain market advantage. To support the capabilities of our staff, we have created an advisory board of industry and communications experts who play important roles on our delivery teams. | ||
| Line 33: | Line 24: | ||
However, Zeno neglects to name any of the members of the board. | However, Zeno neglects to name any of the members of the board. | ||
Website: http://www.pr21.com/default_flash.aspx | Website: http://www.pr21.com/default_flash.aspx | ||
| + | |||
| + | [[Category:Nuclear PR, lobbying and consultancy firms]] | ||
Latest revision as of 01:01, 24 October 2013
|
This article is part of the Nuclear Spin project of Spinwatch. |
Zeno is a PR firm owned by Edelman formerly known as PR21.
Among its clients are British Nuclear Fuels Limited
People
- Jerry A. Epstein President and Chief Executive Officer
- Sue Ryan Chief Executive Zeno Europe
- Phil Armstrong Managing Director and Corporate Public Affairs Lead
- John Berard Managing Director & Technology Lead
- Bridget Brennan Managing Director & Consumer Marketing Lead
- Sheldon Lamphier Managing Director, Human Resources
- Lisa Robinson Managing Director & Head Creative
- Hiroshi Wald Managing Director, Research
- Charlotte Wray Managing Director & Health Care Lead
Advisory Board
Zeno claims to have an Advisory Board, and has this to say about it on its website:
- ZENO approaches each assignment seeking to build the right program to solve a problem, leverage an opportunity or otherwise gain market advantage. To support the capabilities of our staff, we have created an advisory board of industry and communications experts who play important roles on our delivery teams.
- Former biotech executives who understand the necessary dance of drug development and federal oversight, academics who track the leading edge of consumer behavior, financiers who help assess and guide capital formation, non-profit leaders who provide issues insight, and researchers who can get behind the numbers are all part of our team.
However, Zeno neglects to name any of the members of the board. Website: http://www.pr21.com/default_flash.aspx
